타플루프로스트
TAFLUPROST
Nombres e identificadores
TAFLUPROSTINCI타플루프로스트식약처 표준명TAFLUPROST동의어
- cas
- 209860-87-7
- dtxsid
- DTXSID401021504
- dtxcid
- DTXCID601506522
- IUPAC
- Propan-2-yl (5Z)-7-{(1R,2R,3R,5S)-2-[(1E)-3,3-difluoro-4-phenoxybut-1-en-1-yl]-3,5-dihydroxycyclopentyl}hept-5-enoate
- 분자식
- C25H34F2O5
- 분자량
- 452.539 g/mol
Funciones cosméticas
HAIR CONDITIONING
Referencias de seguridad y regulación
Other restriction: ban substances that deplete the ozone layer
MFDS(식약처) 국가별 사용 제한/금지 기록
식약처 규제 요약: 금지 국가 캐나다 / 제한 국가 없음
식약처 국가별 규제 정보: 캐나다 · 금지
Registros oficiales vinculados
Literatura relacionada
- Effects of Tafluprost on Ocular Blood Flow · 2022
- Effects of 0.0015% preservative-free tafluprost on the equine eye. · 2021
- Efficacy of preserved Tafluprost 0.0015% in lowering intraocular pressure · 2023
- Assessment of the optic nerve head, peripapillary, and macular microcirculation in the newly diagnosed patients with primary open-angle glaucoma treated with topical tafluprost and tafluprost/timolol fixed combination · 2019
- Efficacy and Safety of Switching from Tafluprost to a Tafluprost/Timolol Fixed Combination in Patients With Primary Open-Angle Glaucoma · 2018